Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ITMN-191: Phase Ib started

ITMN and ROG began the multiple-ascending dose Phase Ib MAD trial in 40

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE